2024

1. ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy: the Spanish registry

   Blood

2. Approach to the Epidemiology, Disease Management, and Current Challenges in the Management of Generalized Pustular Psoriasis Through a Survey Conducted Among Spanish Dermatologists

   Actas Dermo-Sifiliograficas

3. Assessing the clinical benefit, safety, and patient-reported outcomes with the use of the PAHcare™ digital platform in pulmonary arterial hypertension: a pilot study

   Frontiers in Public Health, Vol. 12

4. Clinical practice guideline on the management of vestibular schwannoma

   Acta Otorrinolaringologica Espanola, Vol. 75, Núm. 2, pp. 108-128

5. Controversies in the management of anti-TNF therapy in patients with Crohn's disease: a Delphi consensus

   BMJ Open Gastroenterology, Vol. 11, Núm. 1

6. Description of clinical and genetic features of 122 patients included in the Spanish Pompe registry

   Neuromuscular Disorders, Vol. 34, pp. 1-8

7. Does remission in systemic lupus erythematosus according to the 2021 DORIS definition match the treating rheumatologist's judgement?

   Rheumatology (Oxford, England), Vol. 63, Núm. 1, pp. 72-78

8. Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting

   International Journal of Dermatology, Vol. 63, Núm. 4, pp. 503-511

9. Erratum: Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (Genome medicine (2023) 15 1 (22))

   Genome medicine

10. Factors related to the development of high antibody titres against SARS-CoV-2 in convalescent plasma donors from the ConPlas-19 trial

    Vox Sanguinis, Vol. 119, Núm. 1, pp. 27-33

11. Hepatotoxicity as dose-limiting toxicity of the combination of bosutinib and atezolizumab in patients with chronic myeloid leukemia. Results of the ZEROLMC study

    Annals of Hematology

12. Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children

    The Journal of experimental medicine, Vol. 221, Núm. 2

13. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 10-15

14. Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience

    Annals of Hematology, Vol. 103, Núm. 2, pp. 451-461

15. Individualised, perioperative open-lung ventilation strategy during one-lung ventilation (iPROVE-OLV): a multicentre, randomised, controlled clinical trial

    The Lancet Respiratory Medicine, Vol. 12, Núm. 3, pp. 195-206

16. Missed opportunities in HIV diagnosis: A need to close the gap

    Enfermedades Infecciosas y Microbiologia Clinica

17. Multicentre study of cefiderocol for treatment of Gram-negative bacteria infections in critically ill patients

    International Journal of Antimicrobial Agents

18. Prognosis after heart transplant in patients with hypertrophic and restrictive cardiomyopathy. A nationwide registry analysis

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 304-313

19. Prognosis of acute heart failure in patients followed up in nursing homes in Spain: Results from the RICA registry

    Medicina Clinica, Vol. 162, Núm. 4, pp. 157-162

20. Real-world persistence of initial targeted therapy strategy in monotherapy versus combination therapy in patients with chronic inflammatory arthritis

    European Journal of Clinical Investigation, Vol. 54, Núm. 2